According to the report published by Visiongain, the Artificial Synthetic Tendons & Ligaments market is estimated to be at USD 20.3 million in 2020 and is expected to exhibit a CAGR of 11.3% over the forecast period. Increasing incidence of sports injuries is the key factor driving the market. Tendons are specialized, heterogeneous connective tissues that pose a major healthcare threat following trauma. The gold standard method of treatment is primary surgical restoration; however, it is extremely conditional on the magnitude of wounds. An option solution for excellent tissue inclusion and regeneration is tissue engineering. In this study, we glance at the sophisticated biomaterial composites used to enhance cell growth while offering suitable mechanical characteristics for the restoration of tendons and ligaments.
During the restoration of anterior cruciate bone (ACL), artificial ligaments were commonly accepted clinically in the 1980s and 1990s. Then, morbidity and disease transmission from the donor site were displayed in the restoration of ACL using allografts or autographs; on the other hand, all these adverse events could be avoided in a rebuilding surgery using prostheses. They were viewed as successful instruments with such apparent benefits. They would become efficient options to the traditional techniques of restoration of ACL if clinically embraced. In addition, the main results were very beneficial for most of these prostheses, with reduced levels of complication and excellent postoperative regeneration. Different types of synthetic ligaments were developed and introduced to hospitals based on these results; each had its own requirements for design patterns, sewing techniques, and fabric products. However, most of these prostheses were no longer used after 20 years of clinical trials due to elevated complication and error levels. However, some synthetic ligaments persisted and in hospitals, such as the Ligament Augmentation Reinforcement System (LARS) and the Leeds–Keio ligaments, were still available. Recently, new kinds of synthetic ligaments (“Neoligaments” label) have also been implemented in hospitals, including knee, shoulder, and ankle joint elastic tendons and ligaments.
Synthetic products were widely explored for tendon and ligament restoration, including polylactic acid (PLA), polyglycolic acid (PGA), and polylactic co-glycolic acid (PLGA). Synthetics have several benefits associated with large-scale production, restricted transmission of disease, regulated degradation, and greater inclusion of donor tissue. Cell incorporation is difficult without further substance therapy, degradation-related products can be cytotoxic, and the components are mechanically stronger than good musculoskeletal bodies. New tissue engineering methods using composite materials to replicate complicated, nonhomogenous settings in tendons and ligaments have also been defined. Specialized cells were coupled with biomaterials in these composite materials to create complicated, heterogeneous scaffolds with mechanical characteristics regulated. This study will give an outline of the various methods outlined for the use of composite scaffolds for the engineering of tendon and ligament tissue. A thorough review of mechanical characteristics, inclusion of cells / tissues, requirements for achievement, and constraints is discussed in depth.
There are currently several difficulties that need to be resolved for tendon tissue engineering. First, there is no need for a separate normal assessment to identify the mechanical demands for effective tendon regeneration. This should integrate multiple types of mechanical evaluation (including stress and rotating) with distinct methods to tissue engineering to replicate the natural environment. Due to the heterogeneous design of tendons, this is hard to accomplish and enforce. The second task is to tackle and regulate the adjacent tissue’s reaction to the scaffold being implanted. To date, this has been restricted to in vitro apps observing the inherent therapeutic reaction. Furthermore, most surveys of the use of composite materials for tendon and ligament tissue engineering use tiny creatures such as rabbits rather than bigger designs such as sheep or horses. Such constraints are focused on important weight and mechanical differences between designs in vitro and indigenous animal tissues. In addition, the ability to fix the manufactured construction in situ (with suture, anchors) and the availability of shelf life should be considered when testing a model. In reality, the scaffold-tendon or scaffold-bone interaction is the location where the scaffolds themselves are at danger of rupture after implantation.
Current status in clinical application
With the growth of sophisticated biomaterials and sophisticated surgical methods with stronger surgical instruments in latest years, concern in using synthetic grafts has been rekindled in ligament reconstruction. When we start talking about the present state of synthetic ligaments in clinical apps, we need to relate to LARS, which orthopedists in China have recently kept in excellent grace. Biomechanical studies have shown that the PET-weaved LARS ligament has adequate power as a graft for restoration of ACL.
Why you should buy Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030: Forecasts and Analysis by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Spine Injuries, and Hip Injuries), End-Use (Hospitals and Clinics, Ambulatory Surgery Centers), By Material (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-Co-Glycolic Acid (PLGA)) and Geography, with Profiles of Leading Companies.
What is the future of the Artificial Synthetic Tendons & Ligaments market? Visiongain’s comprehensive analysis contains highly quantitative content delivering solid conclusions benefiting your analysis and illustrates new opportunities and potential revenue streams helping you to remain competitive. This definitive report will benefit your decision making and help to direct your future business strategy.
We guarantee in this 171 page report you will receive the following key information –
– View Artificial Synthetic Tendons & Ligaments market forecasts and analysis from 2020-2030 to keep you ahead of your competitors and ensure you exploit key business opportunities
– The report provides detailed sales projections of the market, the competitors, and the commercial drivers and restraints allowing you to more effectively compete in the market. In addition to market forecasts from 2020-2030, our new study shows current market data, original critical analysis, and revealing insight into commercial developments
– Artificial Synthetic Tendons & Ligaments revenue forecast
– Artificial Synthetic Tendons & Ligaments connections forecast
– Examine 122 tables, charts, and graphs.
– Let our analysts present you with a thorough assessment of the current and future Artificial Synthetic Tendons & Ligaments market prospects.
– This analysis will achieve quicker, easier understanding. Also you will gain from our analyst’s industry expertise allowing you to demonstrate your authority on the Artificial Synthetic Tendons & Ligaments sector
– Discover sales predictions for the key end use submarkets from 2020-2030
– What are the dynamics of the Artificial Synthetic Tendons & Ligaments industry? Which submarkets will generate the most revenue? Use our forecasts and expert insight to grow your business and give you more industry influence. Find where you can gain and how your organisation can succeed. Avoid falling behind. Stay informed about the potential for each of these Artificial Synthetic Tendons & Ligaments submarkets with individual forecasts and analysis from 2020-2030.
– Application submarket forecast 2020-2030
– End-Use submarket forecast 2020-2030
– submarket forecast 2020-2030
– Learn about the market prospects for the leading Artificial Synthetic Tendons & Ligaments market segments 2020-2030
– How will various value chain members perform over the forecast period? Discover where the highest revenue potential lies from 2020-2030, learning about how Artificial Synthetic Tendons & Ligaments revenue trickles down through the various market segments. These forecasts will also reveal the competitive landscape. You will see what is happening, explaining the challenges, trends, competitors, and market opportunities. Our report reveals forecasts for the 3 leading segmentations as follows.
– Application Revenue Forecast 2020-2030
– Foot and Ankle Injuries Market Forecast, 2020-2030
– Shoulder Injuries Market Forecast, 2020-2030
– Knee Injuries Market Forecast, 2020-2030
– Other Application Market Forecast, 2020-2030
– End-Use Revenue Forecast 2020-2030
– Ambulatory Surgery Centers Market Forecast, 2020-2030
– Hospitals and Clinics Market Forecast, 2020-2030
– Other End-Use Market Forecast, 2020-2030
– Material Revenue Forecast 2020-2030
– Polylactic Acid (PLA) Market Forecast, 2020-2030
– Polyglycolic Acid (PGA) Market Forecast, 2020-2030
– Polylactic-Co-Glycolic Acid (PLGA) Market Forecast, 2020-2030
– Other Material Market Forecast, 2020-2030
– Understand the prospects for the 4 regional and the leading 12 national Artificial Synthetic Tendons & Ligaments markets – where will the highest revenues and opportunities occur?
– Learn about the market potential for Artificial Synthetic Tendons & Ligaments companies in the developed and developing countries, from 2019 onwards. You will see where and how opportunities exist with revealing individual market forecasts and analysis from 2020-2030 for 12 leading national markets by revenue, as well as segmented regional forecasts
– North America Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– US Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Canada Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Mexico Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– North America Artificial Synthetic Tendons & Ligaments by Application revenue forecast 2020-2030
– North America Artificial Synthetic Tendons & Ligaments by End-Use revenue forecast 2020-2030
– North America Artificial Synthetic Tendons & Ligaments by revenue forecast 2020-2030
– Asia Pacific Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– China Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Japan Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– India Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Australia Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Rest of Asia Pacific Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Asia Pacific Artificial Synthetic Tendons & Ligaments by Application revenue forecast 2020-2030
– Asia Pacific Artificial Synthetic Tendons & Ligaments by End-Use revenue forecast 2020-2030
– Asia Pacific Artificial Synthetic Tendons & Ligaments by revenue forecast 2020-2030
– European Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Germany Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– UK Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– France Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Italy Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Spain Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Rest of Europe Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– European Artificial Synthetic Tendons & Ligaments by Application revenue forecast 2020-2030
– European Artificial Synthetic Tendons & Ligaments by End-Use revenue forecast 2020-2030
– European Artificial Synthetic Tendons & Ligaments by revenue forecast 2020-2030
– Rest of World Artificial Synthetic Tendons & Ligaments revenue forecast 2020-2030
– Rest of World Artificial Synthetic Tendons & Ligaments by Application revenue forecast 2020-2030
– Rest of World Artificial Synthetic Tendons & Ligaments by End-Use revenue forecast 2020-2030
– Rest of World Artificial Synthetic Tendons & Ligaments by revenue forecast 2020-2030
– Explore the factors affecting Artificial Synthetic Tendons & Ligaments product developers, and everyone within the value chain. Learn about the forces influencing market dynamics.
– Discover what the present and future outlook for business will be. Learn about the following business critical issues
– Research and development (R&D) strategy
– Technological issues and constraints.
– Competition from new product types
– Increasing specialisation by leading players
– Increasing industry consolidation.
– Advances in product quality
– Analysis of barriers to entry
– Identify who the leading companies are in the Artificial Synthetic Tendons & Ligaments industry
– Our report reveals the technologies and companies which hold the greatest potential. In particular, exploring and analyzing the activities of these companies: See where the expected gains will be. View visiongain’s assessment of the prospects for established competitors, rising companies, and new market entrants. Our work explains that potential, helping you stay ahead. Gain a thorough understanding of the competitive landscape with profiles of 10 leading Artificial Synthetic Tendons & Ligaments companies examining their positioning, capabilities, product portfolios, R&D activity, services, focus, strategies, M&A activity, and future outlook.
Leading Companies in the Global Artificial Synthetic Tendons & Ligaments Market
Corin Group
Advanced Orthopaedic Solutions
Arthrex, Inc.
Artelon
Mathys AG Bettlach
Shanghai Pine & Power Biotech Co., Ltd.
FX Solutions S.A.S.
Orthomed
Cousin Biotech
Xiros Ltd. Integra Lifesciences
Discover Information found nowhere else in this independent assessment of the Artificial Synthetic Tendons & Ligaments market
The Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030: Forecasts and Analysis By Application, By End-Use, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Artificial Synthetic Tendons & Ligaments sector analysis. With the independent business intelligence found only in our work, you will discover where the prospects are for profit. In particular, our new research provides you with key strategic advantages: Our informed forecasts, independent and objective analysis, exclusive interviews and revealing company profiles will provide you with that necessary edge, allowing you to gain ground over your competitors.
With this report you are less likely to fall behind in knowledge or miss crucial business opportunities. You will save time and receive recognition for your market insight. See how you this report could benefit and enhance your research, analysis, company presentations and ultimately your individual business decisions and your company’s prospects.
What makes this report unique?
Visiongain’s research methodology involves an exclusive blend of primary and secondary sources providing informed analysis. This methodology allows insight into the key drivers and restraints behind market dynamics and competitive developments. The report therefore presents an ideal balance of qualitative analysis combined with extensive quantitative data including global, submarket and regional markets forecasts from 2020-2030
How the Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030: Forecasts and Analysis By Application, By End-Use, By and and Geography, with Profiles of Leading Companies report can benefit you
Visiongain’s report is for anyone requiring analysis of the Artificial Synthetic Tendons & Ligaments market. You will discover market forecasts, technological trends, predictions and expert opinion providing you with independent analysis derived from our extensive primary and secondary research. Only by purchasing this report will you receive this critical business intelligence revealing where revenue growth is likely and where the lucrative potential market prospects are. Don’t miss this key opportunity to gain a competitive advantage.
Avoid falling behind your competitors, overlooking critical business opportunities or losing industry influence. In our new report you will discover forecasts from 2020-2030 at the global, submarket, and national level. The report also assesses technologies, competitive forces and expected product pipeline developments. Read on to discover the prospects for the Artificial Synthetic Tendons & Ligaments sector and find out what its future market prospects are.
If you buy our report today your knowledge will stay one step ahead of your competitors. Discover how our report could benefit your research, analyses and strategic decisions, saving you time. To gain an understanding of how to tap into the potential of this market and stay one step ahead of the competition you must order now our report the Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030: Forecasts and Analysis By Application, By End-Use, By and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Artificial Synthetic Tendons & Ligaments sector analysis. Avoid missing out – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Report Overview
1.1 Global Artificial Synthetic Tendons & Ligaments Market Definition
1.2 Global Artificial Synthetic Tendons & Ligaments Market Overview
1.3 Global Artificial Synthetic Tendons & Ligaments Market Segmentation
1.4 Research Scope of Artificial Synthetic Tendons & Ligaments in the Industry
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Methodology
1.8.1 Secondary Research
1.8.2 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to Artificial Synthetic Tendons & Ligaments Systems Market
2.1 Market Definition
2.2 Industry Structure
2.3 Industry Outlook
2.4 Current Status & Trends
2.4.1 Rising research activities on artificial tendons and ligaments
2.4.2 increasing preference for minimally invasive surgeries
2.4.3 Increasing incidences of sports injuries
2.4.4 Presence of alternative procedures and high failure rate of surgeries
2.5 Product Penetration & growth prospect Analysis
2.5.1 Advanced manufacturing process innovation
3. Global Artificial Synthetic Tendons & Ligaments Market Analysis
3.1 PEST Analysis of the Artificial Synthetic Tendons & Ligaments Market
3.2 Expert Opinion
3.2.1 Primary Correspondents
3.3 Market Outlook
3.4 Drivers & Restraints
3.5 Dominant Region/Country
3.6 Market Scenario
3.7 Overall Growth Rate, Globally
3.8 SWOT Analysis of the Artificial Synthetic Tendons & Ligaments Market
3.8.1 Strengths
3.8.2 Weaknesses
3.8.3 Opportunities
3.8.4 Threats
3.9 Porter’s Five Forces Analysis
3.9.1 Competitive Rivalry
3.9.1.1 Powerful Competitive Strategy
3.9.1.2 Firm Concentration Ratio
3.9.1.3 Degree Of Transparency
3.9.2 Supplier Power
3.9.2.1 Supplier Switching Costs Relative To Firm Switching Costs
3.9.2.2 Supplier Concentration To Firm Concentration Ratio
3.9.2.3 Degree Of Differentiation Of Inputs
3.9.3 Buyer Power
3.9.3.1 Degree Of Dependency Upon Existing Channels Of Distribution
3.9.3.2 Buyer Switching Costs Relative To Firm Switching Costs
3.9.3.3 Buyer Concentration To Firm Concentration Ratio
3.9.4 Threat Of Substitute
3.9.4.1 Buyer Propensity To Substitute
3.9.4.2 Relative Price Performance Of Substitute
3.9.4.3 Perceived Level Of Product Differentiation
3..9.5 Threat Of New Entrant
3.9.5.1 Economies Of Scale
3.9.5.2 Switching Costs Or Sunk Costs
3.9.5.3 Industry Profitability (Market CAGR)
4. Artificial Synthetic Tendons & Ligaments: Global Market Analysis by Segments
4.1 Global Artificial Synthetic Tendons & Ligaments Market Forecast, by Application 2020-2030
4.1.1 Application Overview
4.1.2 Foot and Ankle Injuries Market Forecast, 2020-2030
4.1.3 Shoulder Injuries Market Forecast, 2020-2030
4.1.4 Knee Injuries Market Forecast, 2020-2030
4.1.5 Other Application Market Forecast, 2020-2030
4.2 Global Artificial Synthetic Tendons & Ligaments Market Forecast, by End-Use 2020-2030
4.2.1 End-Use Overview
4.2.2 Ambulatory Surgery Centers Market Forecast, 2020-2030
4.2.3 Hospitals and Clinics Market Forecast, 2020-2030
4.2.4 Other End-Use Market Forecast, 2020-2030
4.3 Global Artificial Synthetic Tendons & Ligaments Market Forecast, by Material 2020-2030
4.3.1 Material Overview
4.3.2 Polylactic Acid (PLA) Market Forecast, 2020-2030
4.3.3 Polyglycolic Acid (PGA) Market Forecast, 2020-2030
4.3.4 Polylactic-Co-Glycolic Acid (PLGA) Market Forecast, 2020-2030
4.3.5 Other Material Market Forecast, 2020-2030
5. Leading Regions in Artificial Synthetic Tendons & Ligaments Market 2020-2030
5.1 Regional Overview
5.1.1 North America
5.1.2 Europe
5.1.3 Asia Pacific
5.1.4 LAMEA
5.1.5 Leading Countries/ Regions
5.2 North America Artificial Synthetic Tendons & Ligaments Market Forecast, 2020-2030
5.2.1 North America Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030
5.2.2 North America Artificial Synthetic Tendons & Ligaments Submarket, By End-Use Forecast 2020-2030
5.2.3 North America Artificial Synthetic Tendons & Ligaments Submarket, By Material Forecast 2020-2030
5.2.4 North America Artificial Synthetic Tendons & Ligaments Submarket, By Country Forecast 2020-2030
5.2.4.1 U.S. Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.2.4.2 Canada Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.2.4.3 Mexico Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.3 Europe Artificial Synthetic Tendons & Ligaments Market Forecast, 2020-2030
5.3.1 Europe Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030
5.3.2 Europe Artificial Synthetic Tendons & Ligaments Submarket, By End-Use Forecast 2020-2030
5.3.3 Europe Artificial Synthetic Tendons & Ligaments Submarket, By Material Forecast 2020-2030
5.3.4 Europe Artificial Synthetic Tendons & Ligaments Submarket, By Country Forecast 2020-2030
5.3.4.1 U.K. Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.3.4.2 Germany Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.3.4.3 France Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.3.4.4 Italy Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.3.4.5 Spain Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.3.4.6 The Netherlands Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.3.4.7 Rest of Europe Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.4 Asia-Pacific Artificial Synthetic Tendons & Ligaments Market Forecast, 2020-2030
5.4.1 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030
5.4.2 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket, By End-Use Forecast 2020-2030
5.4.3 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket, By Material Forecast 2020-2030
5.4.4 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket, By Country Forecast 2020-2030
5.4.4.1 China Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.4.4.2 India Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.4.4.3 Japan Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.4.4.4 Korea Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.4.4.5 Indonesia Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.4.4.6 Australia Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.4.4.7 Rest of Asia-Pacific Artificial Synthetic Tendons & Ligaments Market, Forecast 2020-2030
5.5 Rest of World Artificial Synthetic Tendons & Ligaments Market Forecast, 2020-2030
5.5.1 Rest of World Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030
5.5.2 Rest of World Artificial Synthetic Tendons & Ligaments Submarket, By End-Use Forecast 2020-2030
5.5.3 Rest of World Artificial Synthetic Tendons & Ligaments Submarket, By Material Forecast 2020-2030
6. Leading Companies in The Artificial Synthetic Tendons & Ligaments Market
6.1 Corin Group
6.1.1 Corin Group Overview
6.1.2 Analysis of Corin Group Products and Services
6.1.3 Corin Group Primary Market Competitors 2019
6.1.4 Corin Group Key Developments
6.2 Advanced Orthopaedic Solutions
6.2.1 Advanced Orthopaedic Solutions Company Overview
6.2.2 Analysis of Advanced Orthopaedic Solutions Products and Services
6.2.3 Advanced Orthopaedic Solutions Primary Market Competitors 2019
6.2.4 Advanced Orthopaedic Solutions Key Developments
6.3 Arthrex, Inc.
6.3.1 Arthrex, Inc. Company Overview
6.3.2 Analysis of Arthrex, Inc. Products and Services
6.3.3 Arthrex, Inc. Primary Market Competitors 2019
6.3.4 Arthrex, Inc. Key Developments
6.4 Artelon
6.4.1 Artelon Company Overview
6.4.2 Analysis of Artelon Products and Services
6.4.3 Artelon Primary Market Competitors 2019
6.4.4 Artelon Key Developments
6.5 Mathys AG Bettlach
6.5.1 Mathys AG Bettlach Company Overview
6.5.2 Analysis of Mathys AG Bettlach Products and Services
6.5.3 Mathys AG Bettlach Primary Market Competitors 2019
6.5.4 Mathys AG Bettlach Key Developments
6.6 Shanghai Pine & Power Biotech Co., Ltd.
6.6.1 Shanghai Pine & Power Biotech Co., Ltd. Company Overview
6.6.2 Analysis of Shanghai Pine & Power Biotech Co., Ltd. Products and Services
6.6.3 Shanghai Pine & Power Biotech Co., Ltd. Primary Market Competitors 2019
6.6.4 Shanghai Pine & Power Biotech Co., Ltd. Key Developments
6.7 FX Solutions S.A.S.
6.7.1 FX Solutions S.A.S. Company Overview
6.7.2 Analysis of FX Solutions S.A.S. Products and Services
6.7.3 FX Solutions S.A.S. Primary Market Competitors 2019
6.7.4 FX Solutions S.A.S. Key Developments
6.8 Orthomed
6.8.1 Orthomed Company Overview
6.8.2 Analysis of Orthomed Products and Services
6.8.3 Orthomed Primary Market Competitors 2019
6.8.4 Orthomed Key Developments
6.9 Cousin Biotech
6.9.1 Cousin Biotech Company Overview
6.9.2 Analysis of Cousin Biotech Products and Services
6.9.3 Cousin Biotech Primary Market Competitors 2019
6.9.4 Cousin Biotech Key Developments
6.10 Xiros Ltd. Integra Lifesciences
6.10.1 Xiros Ltd. Integra Lifesciences Company Overview
6.10.2 Analysis of Xiros Ltd. Integra Lifesciences Products and Services
6.10.3 Xiros Ltd. Integra Lifesciences Primary Market Competitors 2019
6.10.4 Xiros Ltd. Integra Lifesciences Key Developments
7. Conclusions and Recommendations
7.1. Key Research Findings
7.2. Conclusion by Geography
7.3. Conclusion by Solution Type
7.4. Strategic Recommendations
8. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain Report Evaluation Form
List of Figures
Figure 1.1 Global Artificial Synthetic Tendons & Ligaments Market Segmentation
Figure 2.1 Artificial Synthetic Tendons & Ligaments Value Chain Analysis
Figure 3.1 Artificial Synthetic Tendons & Ligaments Supply-Demand Analysis
Figure 4.1 Global Artificial Synthetic Tendons & Ligaments Forecast 2020-2030 ($billion, AGR %)
Figure 4.2 Global Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030
Figure 4.3 Global Artificial Synthetic Tendons & Ligaments Submarket Forecast by 2020-2030 ($ billion)
Figure 4.4 Global Artificial Synthetic Tendons & Ligaments Market By Application Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.19 Global Artificial Synthetic Tendons & Ligaments by Submarket By Application Forecast 2020-2030 ($ million)
Figure 4.20 Global Artificial Synthetic Tendons & Ligaments Market, by Share Forecast 2019, 2025, 2029 (% Share)
Figure 4.21 Artificial Synthetic Tendons & Ligaments Market, By End-Use Forecast 2020-2030 ($billion, AGR%)
Figure 4.23 Artificial Synthetic Tendons & Ligaments Market, By System Forecast 2020-2030 ($billion, AGR%)
Figure 4.25 Artificial Synthetic Tendons & Ligaments Market, By Application Forecast 2020-2030 ($billion, AGR%)
Figure 4.27 Artificial Synthetic Tendons & Ligaments Market, By End-Use Forecast 2020-2030 ($billion, AGR%)
Figure 5.1 Regional/Country Artificial Synthetic Tendons & Ligaments Market, by 2020-2030
Figure 5.3 Leading Country/Regional Artificial Synthetic Tendons & Ligaments Market Share, by 2020
Figure 5.4 Leading Country/Regional Artificial Synthetic Tendons & Ligaments Market Share, by 2025
Figure 5.5 Leading Country/Regional Artificial Synthetic Tendons & Ligaments Market Share, by 2030
Figure 5.6 Europe Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.7 Europe Artificial Synthetic Tendons & Ligaments Market, by Forecast 2020-2030
Figure 5.8 Europe Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030
Figure 5.9 Europe Artificial Synthetic Tendons & Ligaments Submarket , By End-Use Forecast 2020-2030
Figure 5.10 Europe Artificial Synthetic Tendons & Ligaments Submarket , By Country Forecast 2020-2030
Figure 5.11 Europe Artificial Synthetic Tendons & Ligaments Submarket , By 2020-2030 ($billion, AGR%)
Figure 5.10 North America Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.11 North America Artificial Synthetic Tendons & Ligaments Market, by Forecast 2020-2030
Figure 5.12 North America Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030
Figure 5.13 North America Artificial Synthetic Tendons & Ligaments Submarket , By End-Use Forecast 2020-2030
Figure 5.14 North America Artificial Synthetic Tendons & Ligaments Submarket , By Forecast 2020-2030
Figure 5.13 North America Artificial Synthetic Tendons & Ligaments Submarket , By Country Forecast 2020-2030
Figure 5.14 Asia-Pacific Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030 ($billion , AGR%)
Figure 5.15 Asia-Pacific Artificial Synthetic Tendons & Ligaments Market, by Forecast 2020-2030
Figure 5.16 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030
Figure 5.17 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket , By Country Forecast 2020-2030
Figure 5.17 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket , By Forecast 2020-2030
Figure 5.18 Rest of World Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030 ($billion, AGR%)
Figure 5.19 Rest of World Artificial Synthetic Tendons & Ligaments Market, by Forecast 2020-2030
Figure 5.20 Rest of World Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030
Figure 5.21 Rest of World Artificial Synthetic Tendons & Ligaments Submarket , By End-Use Forecast 2020-2030
Figure 5.21 Rest of World Artificial Synthetic Tendons & Ligaments Submarket , By Forecast 2020-2030
Figure 6.1 3M Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.2 Advanced Orthopaedic Solutions Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.3 Arthrex, Inc. Total Company Sales 2013-2019 (US$ Bn, AGR %)
Figure 6.6 Artelon Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.7 Artelon Revenue % Share, by Segment, 2019
Figure 6.8 Artelon Revenue % Share, by Geographical Trade, 2019
Figure 6.9 Artelon Revenue % Share, by Business Segment, 2019
Figure 6.10 Mathys AG Bettlach Revenue % Share, by Geographic Segment, 2019
Figure 6.11 Shanghai Pine & Power Biotech Co., Ltd. Company Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.12 FX Solutions S.A.S. Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.13 FX Solutions S.A.S. Revenue % Share, by Regional Segment, 2019
Figure 6.14 Orthomed Total Company Sales 2013-2019 (US$ million, AGR %)
Figure 6.15 Orthomed Revenue % Share, by Regional Segment, 2019
Figure 6.16 Orthomed Revenue % Share, by Business Segment, 2019
Figure 6.17 Cousin Biotech Total Company Sales 2013-2019 (US$ bn, AGR %)
Figure 6.18 Xiros Ltd. Integra Lifesciences Total Company Revenue 2013-2019 (US$ bn, AGR %)
Figure 6.19 Xiros Ltd. Integra Lifesciences Company Sales 2014-2019 (US$ bn, AGR %)
Figure 6.20 Xiros Ltd. Integra Lifesciences Revenue % Share, by Business Segment, 2019
List of Tables
Table 1.0 Research Scope
Table 4.1 Global Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030 ($Bn, AGR %, CAGR %)
Table 4.2 Global Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 4.3 Global Artificial Synthetic Tendons & Ligaments Submarket, By Material Forecast 2020-2030 ($billion, AGR %)
Table 5.1 Global Artificial Synthetic Tendons & Ligaments Market, by Country/Region Forecast 2020-2030 ($billion, AGR %)
Table 5.3 Europe Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.4 Europe Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.5 Europe Artificial Synthetic Tendons & Ligaments Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.6 North America Artificial Synthetic Tendons & Ligaments Market Submarket, By Material Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.7 North America Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.8 North America Artificial Synthetic Tendons & Ligaments Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.9 Asia-Pacific Artificial Synthetic Tendons & Ligaments Market Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.10 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.11 Asia-Pacific Artificial Synthetic Tendons & Ligaments Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 5.12 Rest of World Artificial Synthetic Tendons & Ligaments Market Submarket, By Material Forecast 2020-2030 ($billion, , AGR %, CAGR %)
Table 5.13 Rest of World Artificial Synthetic Tendons & Ligaments Submarket, By Application Forecast 2020-2030 ($billion, AGR %)
Table 5.14 Rest of World Artificial Synthetic Tendons & Ligaments Submarket, By End-Use Forecast 2020-2030 ($billion, AGR %)
Table 6.1 3M Profile 2019 (Market Entry, Public/Private, Headquarters, Geography, Key Market, Listed on, Products/Services
Table 6.2 3M Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.3 3M Products and Services (Product/Service, Segment)
Table 6.4 3M Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.5 3M Total Company Recent Development 2015-2019
Table 6.6 Advanced Orthopaedic Solutions Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.7 Advanced Orthopaedic Solutions Products and Services (Product/Service, Segment)
Table 6.8 Advanced Orthopaedic Solutions Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.9 Advanced Orthopaedic Solutions Total Company Recent Development 2015-2019
Table 6.10 Arthrex, Inc. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.11 Arthrex, Inc. Products and Services (Product/Service, Segment)
Table 6.12 Arthrex, Inc. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.13 Arthrex, Inc. Total Company Recent Development 2015-2019
Table 6.14 Artelon Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.15 Artelon Products and Services (Product/Service, Segment)
Table 6.16 Artelon Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.17 Artelon Total Company Recent Development 2015-2019
Table 6.18 Mathys AG Bettlach Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.19 Mathys AG Bettlach Products and Services (Product/Service, Segment)
Table 6.20 Mathys AG Bettlach Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.21 Mathys AG Bettlach Total Company Recent Development 2015-2019
Table 6.22 Shanghai Pine & Power Biotech Co., Ltd. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.23 Shanghai Pine & Power Biotech Co., Ltd. Products and Services (Product/Service, Segment)
Table 6.24 Shanghai Pine & Power Biotech Co., Ltd. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.25 Shanghai Pine & Power Biotech Co., Ltd. Total Company Recent Development 2015-2019
Table 6.26 FX Solutions S.A.S. Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.27 FX Solutions S.A.S. Products and Services (Product/Service, Segment)
Table 6.28 FX Solutions S.A.S. Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.29 FX Solutions S.A.S. Total Company Recent Development 2015-2019
Table 6.30 Orthomed Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.31 Orthomed Products and Services (Product/Service, Segment)
Table 6.32 Orthomed Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.33 Orthomed Total Company Recent Development 2015-2019
Table 6.34 Cousin Biotech Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.35 Cousin Biotech Products and Services (Product/Service, Segment)
Table 6.36 Cousin Biotech Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.37 Cousin Biotech Total Company Recent Development 2015-2019
Table 6.38 Xiros Ltd. Integra Lifesciences Profile 2019 (CEO, Total Company Sales US$m, Sales in the Market US$m, Share of Company Sales from MHealth Market %, Net Income / Loss US$m, Strongest Business Region, Business Segment in the Market, Submarket Involvement, HQ, Founded, No. of Employees, Website)
Table 6.39 Xiros Ltd. Integra Lifesciences Products and Services (Product/Service, Segment)
Table 6.40 Xiros Ltd. Integra Lifesciences Total Company Sales 2015-2019 (US$billion, AGR %)
Table 6.41 Xiros Ltd. Integra Lifesciences Total Company Recent Development 2015-2019
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
